Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37833878)

  • 1. Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat.
    Vera G; López-Gómez L; Girón R; Martín-Fontelles MI; Nurgali K; Abalo R; Uranga JA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat.
    Abalo R; Uranga JA; Pérez-García I; de Andrés R; Girón R; Vera G; López-Pérez AE; Martín-Fontelles MI
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27686064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
    Pascual D; Goicoechea C; Suardíaz M; Martín MI
    Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy.
    Vera G; Cabezos PA; Martín MI; Abalo R
    Pharmacol Biochem Behav; 2013 Apr; 105():205-12. PubMed ID: 23454533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat.
    Vera G; Chiarlone A; Cabezos PA; Pascual D; Martín MI; Abalo R
    Life Sci; 2007 Jul; 81(6):468-79. PubMed ID: 17673260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
    Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
    Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.
    Vera G; López-Miranda V; Herradón E; Martín MI; Abalo R
    Pharmacol Biochem Behav; 2012 Aug; 102(2):335-43. PubMed ID: 22609797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
    Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
    Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
    Ulugol A; Karadag HC; Ipci Y; Tamer M; Dokmeci I
    Neurosci Lett; 2004 Nov; 371(2-3):167-70. PubMed ID: 15519750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat.
    Abalo R; Cabezos PA; Vera G; López-Pérez AE; Martín MI
    Neurogastroenterol Motil; 2013 May; 25(5):373-82, e292. PubMed ID: 23594243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
    Hama A; Sagen J
    Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.
    Potenzieri C; Harding-Rose C; Simone DA
    Brain Res; 2008 Jun; 1215():69-75. PubMed ID: 18486111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
    Johanek LM; Simone DA
    Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a rat model.
    Linsell O; Brownjohn PW; Nehoff H; Greish K; Ashton JC
    J Drug Target; 2015 May; 23(4):353-9. PubMed ID: 25541465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
    Liang YC; Huang CC; Hsu KS
    Neuropharmacology; 2007 Jul; 53(1):169-77. PubMed ID: 17572451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.
    Doğrul A; Gül H; Yildiz O; Bilgin F; Güzeldemir ME
    Neurosci Lett; 2004 Sep; 368(1):82-6. PubMed ID: 15342139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.
    Hama A; Sagen J
    J Rehabil Res Dev; 2009; 46(1):135-43. PubMed ID: 19533526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
    Johanek LM; Heitmiller DR; Turner M; Nader N; Hodges J; Simone DA
    Pain; 2001 Sep; 93(3):303-315. PubMed ID: 11514089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain.
    Costa B; Colleoni M; Conti S; Trovato AE; Bianchi M; Sotgiu ML; Giagnoni G
    Br J Pharmacol; 2004 Jan; 141(1):4-8. PubMed ID: 14662732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.